• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Symplr to Acquire Halo Health

Share:

September 21, 2021

symplr®, the leader in enterprise healthcare operations including governance, risk management and compliance (“GRC”) SaaS solutions, backed by Clearlake Capital Group, L.P. (together with its affiliates, “Clearlake”) and Charlesbank Capital Partners (“Charlesbank”), announced today that it has agreed to acquire Halo Health, a provider of clinical communication and collaboration software that streamlines clinical processes and interactions, improving clinician satisfaction and patient care. The terms of the transaction were not disclosed.

“Halo Health is an exciting addition to the symplr family, as it addresses our clients’ critical need to improve clinical communication,” said BJ Schaknowski, CEO of symplr. “Halo Health’s modern approach to digital communication facilitates the rapid exchange of information, streamlines workflows, and improves patient safety. The company’s unified communication and collaboration platform consolidate outdated technology like pagers, feature phones, and legacy texting applications, presenting a strong return on investment opportunity for customers.”

Founded by clinicians, for clinicians, Halo Health helps healthcare organizations standardize and streamline clinical communication and workflows, consolidate technology, and connect clinical communities. The Halo Clinical Collaboration Platform (“CCP”) is a cost-effective, cloud-based system that unifies all communication channels, including secure messaging, video, voice, and alerts, and enables role-based collaboration to ensure the right message gets to the right person, role, or team, instantly. Halo Health bolsters symplr’s rapidly growing workforce and talent management portfolio with the addition of on-call scheduling, which allows for easy management of schedules, monitoring of on-call status changes in real-time, and automation of role-based communication.

“Joining symplr will allow us to further expand the reach of the Halo Clinical Collaboration Platform,” said Jose Barreau, M.D., CEO of Halo Health. “Our top rating in the KLAS clinical communication and collaboration category demonstrates that we continue to meet the needs of healthcare systems nationwide, and we look forward to extending that leadership as we unite with the symplr family of healthcare operations software solutions.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Over the last several years, we have partnered with the symplr management team to execute on several strategic acquisitions, and Halo Health is another strong addition in this journey to create the most comprehensive healthcare GRC SaaS platform,” said Behdad Eghbali, Co-Founder and Managing Partner of Clearlake.

Ryan Carroll, Managing Director of Charlesbank, added, “We look forward to supporting the Halo team through this investment and further building on symplr’s strong track record of creating additional value for its customers.”

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • PE Firm Thoma Bravo Acquires Clinical Trial Financial Platform Greenphire – Health M&APE Firm Thoma Bravo Acquires Clinical Trial Financial Platform Greenphire – Health M&A
  • Health IT company Medsphere Systems Corporation acquires Wellsoft to increase ED capabilitiesHealth IT company Medsphere Systems Corporation acquires Wellsoft to increase ED capabilities
  • ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
  • Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in RevenueSunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue
  • Evoke Acquires Navience Healthcare Solutions, LLCEvoke Acquires Navience Healthcare Solutions, LLC
  • R1 Announces Sale of its Emergency Medical Services Business to Sarnova Holdings, Inc.
  • 2021 Pipeline Insights Into Scleroderma – Key Players Include Corbus Pharmaceuticals, Gesynta Pharma and Formation Biologics2021 Pipeline Insights Into Scleroderma – Key Players Include Corbus Pharmaceuticals, Gesynta Pharma and Formation Biologics
  • Biotech R&D Platform Benchling Closes $100M at $6B ValuationBiotech R&D Platform Benchling Closes $100M at $6B Valuation

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications